Dallas Allergy Immunology Clinical Research entered the industry of Allergists in 0 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code , which describes it as a Allergists. For further clarification, the SIC classifies this business under the code and described it as a Allergists. The business provides service to the B2C market.
To acquire more information, please contact DAI PDAI by calling (972) 566-7471 during business hours. You can also write to the business’ Single Location at 7777 Forest Lane, Suite B332, Dallas, Texas TX 75230. You can also visit the company’s website at dallasallergy.net/services/clinical-research-studies. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Dallas Allergy Immunology Clinical Research |
Representative: | DAI PDAI |
Place of Business: | 7777 Forest Lane, Suite B332, Dallas, TX 75230 |
Contact Number: | (972) 566-7471 |
Website: | dallasallergy.net/services/clinical-research-studies |
Type of Service: | Allergists |
Locality: | Single Location |
Market Type: | B2C (Business to Consumer) |
Income/Year: | $500.000 to $999.999 |
Laborers: | 1 to 4 |
Share This Company: |
Dallas Allergy Immunology Clinical Research is a company operating from Dallas, Texas providing professional Allergists and relevant B2C variables. It was founded in 0 and registered with the SIC code as Allergists, and with the NAICS code as Allergists.
With a current employee count of 1 to 4, Dallas Allergy Immunology Clinical Research has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative DAI PDAI at (972) 566-7471 for related queries, or to locate its Single Location using the coordinates +32.909587,-096.772134.
The Single Location can also be found at the street address 7777 Forest Lane, Suite B332 in Dallas, Texas 75230 and can be engaged online through the company website at dallasallergy.net/services/clinical-research-studies, the company Twitter , and Facebook page .